Actively Recruiting
Donor Outcomes Following Hand-Assisted and Robotic Living Donor Nephrectomy: a Retrospective Review
Led by Methodist Health System · Updated on 2024-11-20
240
Participants Needed
1
Research Sites
N/A
Total Duration
On this page
AI-Summary
What this Trial Is About
This research aims to compare patient outcomes between two minimally invasive kidney transplant methods—hand-assisted and robotic nephrectomy—used in living donors. Kidney transplantation is preferred for patients with end-stage kidney disease, offering better life expectancy and quality of life than dialysis. Living donor transplants provide advantages in graft function and timing, and minimally invasive techniques have increased living donation rates by reducing complications and recovery time. The study is a retrospective review of clinical data from donors and recipients who received either hand-assisted or robotic minimally invasive kidney transplants at a single center between January 2006 and November 2019. Data include patient demographics, surgical details, hospital stay, complications, and costs. This comparison will help understand differences in outcomes between the two surgical approaches. Participants' data will be collected from electronic medical records, focusing on variables such as operating room time, warm ischemia time, estimated blood loss, complication rates, length of hospital stay, readmissions within 30 days, body mass index, hospital costs, and kidney function at discharge. The study covers all eligible donors and recipients treated during the specified period, with no follow-up beyond the hospital discharge and readmission data.
CONDITIONS
Brief Title
Donor Outcomes Following Hand-Assisted and Robotic Living Donor Nephrectomy: a Retrospective Review
Who Can Participate
Eligibility Criteria
You may qualify if you...
- 18 years of age or older
- Kidney donors and recipients who underwent a hand-assisted or robotic kidney transplant
You will not qualify if you...
- Patients who do not meet the study inclusion criteria listed above
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Data collected from procedures performed between January 2006 and November 2019
Participants underwent minimally invasive kidney transplantation procedures which are reviewed retrospectively through medical records.
No visits; data collected retrospectively from medical records
Duration - Up to 30 days post-procedure
Participants' clinical outcomes including complications, readmissions, and kidney function are observed retrospectively after the kidney transplant procedure.
No visits; outcomes assessed through medical records review
Trial Site Locations
Total: 1 location
1
The Liver Institute at Methodist Dallas Medical Center
Dallas, Texas, United States, 75203
Actively Recruiting
Research Team
C
Crystee Cooper, DHEd
Z
Zaid Haddadin, MS
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here